Searching journal content for animal models (as phrase) in full text.

Displaying results 1-10 of 245
For checked items
  1. ...animal models to reduce cancer cell 38 proliferation, cell migration and angiogenesis (Mousa, et al. 2008; Mousa, et al. 2012; 39 Rebbaa, et al. 2008; Yalcin, et al. 2009), to induce apoptosis in tumor cells (Glinskii, et 40 al. 2009; Yalcin, et al. 2010) and to foster DNA double-strand breaks (Hber ~~~
  2. ...animal models for MEN1 research and provide us with their vision for future developments (Mohr & Pellegata 2017). The management of patients with MEN1 has changed dramatically over the last two decades. We are able to control gastric acid hypersecretion due to Zollinger– Ellison Syndrome (ZES) as on ~~~
  3. ...animal models of the MEN1 syndrome have been generated in different organisms by introducing loss-of-function mutations in the orthologues of the human MEN1 gene. In this review, we will discuss MEN1 and MEN1-like models in Drosophila, mice and rats. These model systems with their specific advantage ~~~
  4. ...animal models augments immune responses, resulting in the 84 rejection of tumors, including pre-established tumors. Interestingly, this also results in immunity 85 against secondary exposure to tumor cells, suggesting that the memory component of immune 86 response can be evoked by anti CTLA-4 antib ~~~
  5. ...animal models ~~~
  6. ...animal models (Pai et al. 2006, Akar  et  al. 2008, Qin  et  al. 2013, Zhang  et  al. 2013b). Long-lasting RNAi-based gene silencing can also be achieved using lentivirus-based expression systems (Park 2007). Nonetheless, significant obstacles such as in vivo delivery, partial suppression of target ~~~
  7. ...animal models bearing castration-resistant, enzalutamideresistant xenografts, treatment with bromodomain inhibitors decreased AR-V7 production in association with a decrease in U2AF65 and ASF/SF2 mRNA (Asangani et al. 2016). Several studies have also demonstrated that both c-MYC and NF-kappaB2/p52 i ~~~
  8. ...animal models ~~~
  9. ...animal models (Gilmore  et  al. 2009). This is a potential mechanism of non-endocrine neoplasia induced hypalcaemia. Breast and testicular malignancies, and certain haematological malignancies including multiple myeloma, lymphomas and chronic lymphocytic leukaemia, can cause hypalcaemia via this mec ~~~
  10. ...animal models investigated (Verlinden  et  al. 2000, Swami et al. 2012). This enhanced potency in blocking cell proliferation when combined with its lower calcaemic-inducing properties prompted us to further investigate inecalcitol as a potential new therapeutic for breast cancer. Here, we show that ~~~
For checked items